Application of Pharmacodynamic Modeling for Designing Time-Variant Dosing Regimens to Overcome Nitroglycerin Tolerance in Experimental Heart Failure
暂无分享,去创建一个
[1] U. Elkayam,et al. Escalating nitrate dose overcomes early attenuation of hemodynamic effect caused by nitrate tolerance in patients with heart failure. , 1995, American heart journal.
[2] Fung Ho-leung,et al. Relationship between nitroglycerin-induced vascular relaxation and nitric oxide production: Probes with inhibitors and tolerance development , 1993 .
[3] J. Bauer,et al. Effects of chronic glyceryl trinitrate on left ventricular haemodynamics in a rat model of congestive heart failure: demonstration of a simple animal model for the study of in vivo nitrate tolerance. , 1990, Cardiovascular research.
[4] S L Shafer,et al. Pharmacokinetics, pharmacodynamics, and rational opioid selection. , 1991, Anesthesiology.
[5] M. Ferratini,et al. Intermittent transdermal nitroglycerin monotherapy in stable exercise-induced angina: a comparison with a continuous schedule. , 1989, European heart journal.
[6] J. Bauer,et al. Concurrent Hydralazine Administration Prevents Nitroglycerin‐Induced Hemodynamic Tolerance in Experimental Heart Failure , 1991, Circulation.
[7] D. Harrison,et al. Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance. , 1995, The Journal of clinical investigation.
[8] L. Benet,et al. In vivo depletion of free thiols does not account for nitroglycerin-induced tolerance: a thiol-nitrate interaction hypothesis as an alternative explanation for nitroglycerin activity and tolerance. , 1996, The Journal of pharmacology and experimental therapeutics.